Kalkine has a fully transformed New Avatar.
Amplia Therapeutics Limited (ASX:ATX)is an ASX-listed pharmaceutical company that develops FAK inhibitors to treat fibrotic cancers like pancreatic and ovarian cancer, as well as chronic diseases including idiopathic pulmonary fibrosis (IPF).
Multiple brokerages including Macquarie and Canaccord Genuity reaffirm BUY ratings on West African Resources
Highlights:
Orthocell generates its first U.S. revenue from flagship nerve repair product, Remplir™.
Artrya signs five-year commercial SaaS agreement with Tanner Health, valued at US$0.6 million.
Highlights
ASX 200 rises 0.6% to 8,587.70, led by banks, miners, and tech stocks.
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine! Start Your 7-Days Free Trial Today!
Continue
AU
CA
NZ
UK
US
IND
Please wait processing your request...